🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆
Clinical Trials in Egypt / NCT07566676
Recruiting Not applicable

Maxillary Incisor Intrusion Using Utility Arch Assisted With Micro-osteoperforations

NCT07566676 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2026-05
Last updated
2026-05-05

Condition(s) studied

Deep Bite MalocclusionIntrusion of ToothOrthodontic Tooth MovementRoot Resorption

Investigational drug(s) / intervention(s)

Micro-osteoperforationsUtility arch

Micro-osteoperforations: Using utility arch with micro-osteoperforations (MOPs). The biologic mechanism behind MOPs is to increase the cytokine expression that leads to increase bone resorption and the catabolic phase of tooth movement in the direction of tooth movement. Transmucosal holes in cortical bone are made to trigger bone remodeling changes for faster tooth movement at the apices above maxillary incisors to evaluate the amount of movement and amount of root resorption.

Utility arch: Patients will receive utility arch for intrusion of maxillary incisors without micro-osteoperforations.

Study summary

Study will be directed to evaluate the dentoalveolar changes following maxillary incisor intrusion using utility arch assisted with micro-osteoperforations in deep bite cases.

Eligibility

Sex
ALL
Min age
15 Years
Max age
25 Years
Healthy volunteers
No
Inclusion Criteria: 1. Patients age between 15-25 years. 2. Patients with overbite ≥ 4 mm. 3. All permanent teeth erupted (excluding 3rd molars). 4. No previous orthodontic treatment. 5. Patients with good oral hygiene and good periodontal health. Exclusion Criteria: 1. Skeletal discrepancies. 2. Missing maxillary anterior teeth or any kind of tooth/root shape anomaly. 3. Patients with root resorption or impacted canines. 4. Previous history of orthodontic treatment. 5. Systemic disease interferes with orthodontic tooth movement. 6. History of trauma affecting the maxillary incisors. 7. Poor oral hygiene or periodontally compromised patient. 8. Endodontically treated upper anterior teeth.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Faculty of Dental Medicine (Boys), Al-Azhar University Cairo Nasr City Recruiting

More Al-Azhar University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07566676 on ClinicalTrials.gov ↗ ← All trials in Egypt